Understanding the role of a specific gene in rheumatoid arthritis
Role of PTPN2 in rheumatoid arthritis
This study is looking at how changes in a specific gene might make some people more likely to get rheumatoid arthritis, and it aims to understand how this affects the immune system, with the hope of finding new ways to treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10852548 on NIH RePORTER |
What this research studies
This research investigates how genetic variations in the PTPN2 gene may increase the risk of developing rheumatoid arthritis (RA). By studying mice with reduced PTPN2 expression, researchers aim to uncover the mechanisms that lead to heightened inflammation and severity of arthritis. The study focuses on the behavior of immune cells, particularly regulatory T cells, and how their instability contributes to the disease. Through this work, the researchers hope to identify potential targets for new treatments for RA.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with rheumatoid arthritis or those at risk due to genetic factors.
Not a fit: Patients without rheumatoid arthritis or those with other unrelated autoimmune conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing rheumatoid arthritis.
How similar studies have performed: Other research has shown promising results in understanding genetic factors in autoimmune diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Bottini, Nunzio — Cedars-Sinai Medical Center
- Study coordinator: Bottini, Nunzio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.